retatrutide glp-1 gip glucagon triple agonist A review of an investigational drug retatrutide, a novel agent for the treatment of obesity | European Journal of Clinical Pharmacology Retatrutide 10mg Triple Agonist |
Description
For heart rate measurements, a surface ECG was recorded using custom-made needle electrodes placed on each limb
Jastreboff, et al., 'Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA', Lancet , vol
How are Wegovy and Saxenda different
Review common side effects like constipation , fatigue , and dizziness so your doctor knows you understand the commitment involved
Impact of GLP-1 receptor agonists on psoriasis and cardiovascular comorbidities: a narrative review
10.1056/nejmoa1603827 46 MeurotC.MartinC.SudreL.BretonJ.BougaultC.RattenbachR.et al (2022)
